Searching for foreign antigens as possible triggering factors of autoimmunity: Torque Teno virus DNA prevalence is elevated in sera of patients with bullous pemphigoid

Experimental Dermatology

Volumn 17, Issue 5, 2008, Pages 446-454

  Blazsek, Antal ^a,b,c   Sillo, Palma ^a   Ishii, Norito ^d   Gergely Jr , Peter ^e   Poor, Gyula ^e   Preisz, Klaudia ^a   Hashimoto, Takashi ^d   Medvecz, Márta ^a,b   Kárpáti, Sarolta ^a,b,c  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c Szentagothai Knowledge Center   (Hungary)

^d KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e NATIONAL INSTITUTE OF RHEUMATOLOGY AND PHYSIOTHERAPY   (Hungary)

Author keywords

Autoimmune bullous skin disorders; Bemphigus vulgaris; Bullous pemphigoid; Dermatitis herpetiformis; Torque teno virus

Indexed keywords

AUTOANTIGEN; DESMOGLEIN 3; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; VIRUS ANTIGEN; VIRUS DNA;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNITY; BULLOUS PEMPHIGOID; CELL ASSAY; COMPUTER MODEL; COMPUTER PROGRAM; CONTROLLED STUDY; DERMATITIS HERPETIFORMIS; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE TRANSFORMATION TEST; MAJOR CLINICAL STUDY; MALE; OPEN READING FRAME; PATHOGENESIS; PEMPHIGUS VULGARIS; PERSISTENT VIRUS INFECTION; POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SEROPREVALENCE; TORQUE TENO VIRUS;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; AUTOANTIGENS; AUTOIMMUNITY; DERMATITIS HERPETIFORMIS; DESMOGLEIN 3; DNA VIRUS INFECTIONS; DNA, VIRAL; FEMALE; HUMANS; IMMUNOLOGIC TESTS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PEMPHIGUS; SEQUENCE ANALYSIS, PROTEIN; STATISTICS, NONPARAMETRIC; TORQUE TENO VIRUS; TRANSGLUTAMINASES; VIRAL PROTEINS;

EID: 42049110361     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2007.00663.x     Document Type: Article

References (43)

1. Smith S A, Kotwal G J. Virokines: Novel immunomodulatory agents. Expert Opin Biol Ther 2001: 1: 343-357.
2. Fujinami R S, von Herrath M G, Christen U, Whitton J L. Molecular mimicry, bystander activation, or viral persistence: Infections and autoimmune disease. Clin Microbiol Rev 2006: 19: 80-94.
3. Bendinelli M, Pistello M, Maggi F, Fornai C, Freer G, Vatteroni M L. Molecular properties, biology, and clinical implications of TT virus, a recently identified widespread infectious agent of humans. Clin Microbiol Rev 2001: 14: 98-113.
4. Biagini P. Human circoviruses. Vet Microbiol 2004: 98: 95-101.
5. Irshad M, Joshi Y K, Sharma Y, Dhar I. Transfusion transmitted virus: A review on its molecular characteristics and role in medicine. World J Gastroenterol 2006: 12: 5122-5134.
6. Mayo M A, Ball L A. ICTV in San Francisco: A report from the Plenary Session. Arch Virol 2006: 151: 413-422.
7. Nishizawa T O H, Tsuda F, Aikawa T et al. Quasispecies of TT virus TTV with sequence divergence in hypervariable regions of the capsid protein in chronic TTV infection. J Virol 1999: 73: 9604-9608.
8. Worobey M. Extensive homologous recombination among widely divergent TT viruses. J Virol 2000: 74: 7666-7670.
9. Kamahora T, Hino S, Miyata S. Three spliced mRNAs of TT virus transcribed from a plasmid containing the entire genome in COS1 cells. J Virol 2000: 74: 9980-9986.
10. Seemayer C A, Viazov S, Neidhart M et al. Prevalence of TTV DNA and GBV-C RNA in patients with systemic sclerosis, rheumatoid arthritis, and osteoarthritis does not differ from that in healthy blood donors. Ann Rheum Dis 2001: 60: 806-809.
11. Gergely P Jr, Blazsek A, Danko K, Ponyi A, Poor G. Detection of TT virus in patients with idiopathic inflammatory myopathies. Ann N Y Acad Sci 2005: 1050: 304-313.
12. Gergely P Jr, Pullmann R, Stancato C et al. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. Clin Immunol 2005: 116: 124-134.
13. Osiowy C, Sauder C. Detection of TT virus in human hair and skin. Hepatol Res 2000: 16: 155-162.
14. Onodera Y, Shimizu H, Hashimoto T et al. All autoantibodies against the 230kD bullous pemphigoid antigen BPAG1, and the majority of those against the 180kD bullous pemphigoid antigen BPAG2 bind solely to the epidermal side, but some of those against BPAG2 bind to both epidermal and dermal sides of 1M sodium chloride split skin. J Invest Dermatol 1994: 1025: 686-690.
15. Sugi T, Hashimoto T, Hibi T, Nishikawa T. Production of human monoclonal anti-basement membrane zone BMZ antibodies from a patient with bullous pemphigoid BP by Epstein-Barr virus transformation. Analyses of the heterogeneity of anti-BMZ antibodies in BP sera using them. J Clin Invest 1989: 84: 1050-1055.
16. Matsumura K, Amagai M, Nishikawa T, Hashimoto T. The majority of bullous pemphigoid and herpes gestations serum samples react with NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res 1996: 288: 507-509.
17. Nie Z, Hashimoto T. IgA antibodies of cicatricial pemphigoid sera specifically react with C-terminus of BP180. J Invest Dermatol 1999: 112: 254-255.
18. Yoshida M, Hamada T, Amagai M et al. Enzyme-linked immunosorbent assay using bacterial recombinant proteins of human BP230 as a diagnostic tool for bullous pemphigoid. J Dermatol Sci 2006: 411: 21-30.
19. Sardy M, Odenthal U, Karpati S, Paulsson M, Smyth N. Recombinant human tissue transglutaminase ELISA for the diagnosis of gluten-sensitive enteropathy. Clin Chem 1999: 45: 2142-2149.
20. Altschul S F, Madden T L, Schaffer A A et al. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res 1997: 25: 3389-3402.
21. Schäffer A, Aravind L, Madden T L et al. Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. Nucleic Acids Res 2001: 29: 3389-3402.
22. Kolaskar A S, Tongaonkar P C. A semi-empirical method for prediction of antigenic determinants on protein antigens. FEBS Lett 1990: 2761: 172-174.
23. Sospedra M Z Y, zur Hausen H, Muraro P A et al. Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathog 2005: 1: e41.
24. Pichler W J, Tilch J. The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 2004: 59: 809-820.
25. Giudice G J, Emery D J, Diaz L A. Cloning and primary structural analysis of the bullous pemphigoid autoantigen BP180. J Invest Dermatol 1992: 99: 243-250.
26. Lin M S, Gharia M A, Swartz S J, Diaz L A, Giudice G J. Identification and characterization of epitopes recognized by T lymphocytes and autoantibodies from patients with herpes gestations. J Immunol 1999: 162: 4991-4997.
27. Lin M S, Fu C L, Giudice G J et al. Epitopes targeted by bullous pemphigoid T lymphocytes and autoantibodies map to the same sites on the bullous pemphigoid 180 ectodomain. J Invest Dermatol 2000: 115: 955-961.
28. Lin M S, Fu C L, Olague-Marchan M et al. Autoimmune responses in patients with linear IgA bullous dermatosis: Both autoantibodies and T lymphocytes recognize the NC16A domain of the BP180 molecule. Clin Immunol 2002: 102: 310-319.
29. di Zenzo G, Grosso F, Terracina M et al. Characterization of the anti-BP180 autoantibody reactivity profile and epitope mapping in bullous pemphigoid patients. J Invest Dermatol 2004: 122: 103-110.
30. Hacker-Foegen M K, Zillikens D, Giudice G J, Lin M S. T cell receptor gene usage of BP180-specific T lymphocytes from patients with bullous pemphigoid and pemphigoid gestations. Clin Immunol 2004: 113: 179-186.
31. Thoma-Uszynski S, Uter W, Schwietzke S, Schuler G, Borradori L, Hertl M. Autoreactive T and B cells from bullous pemphigoid (BP) patients recognized epitopes clustered in distinct regions of BP180 and BP230. J Immunol 2006: 176: 2015-2023.
32. Poovorawan Y, Tangkijvanich P, Theamboonlers A, Hirsch P. Transfusion transmissible virus TTV and its putative role in the etiology of liver disease. Hepatogastroenterology 2001: 48: 256-260.
33. Mariscal L F, Lopez-Alcorocho J M, Rodriguez-Inigo E et al. TT virus replicates in stimulated but not in nonstimulated peripheral blood mononuclear cells. Virology 2002: 301: 121-129.
34. Takacs M, Lengyel A, Dencs A, Berencsi G. Newly discovered hepatitis viruses -do they cause hepatitis indeed? Orv Hetil 2003: 14432: 1569-1574.
35. Szladek G, Juhasz A, Kardos G et al. High co-prevalence of genogroup 1 TT virus and human papillomavirus is associated with poor clinical outcome of laryngeal carcinoma. J Clin Pathol 2005: 58: 402-405.
36. Ahmed A R, Rosen G B. Viruses in pemphigus. Int J Dermatol 1989: 28: 209-217.
37. Handley J, O'Neill H, Connolly J, Burrows D. Adenovirus 12 and dermatitis herpetiformis. Acta Derm Venereol 1993: 73: 430-432.
38. Dahl M V, Katz S I, Scott R M, Binn L N. Viral studies in pemphigus. J Invest Dermatol 1974: 62: 96-99.
39. Drago F, Nozza P, Casazza S, Brusati C, Bandelloni R, Rebora A. Human herpesviruses in bullous pemphigoid lesions. Br J Dermatol 2005: 152: 375-376.
40. Erbagci Z. Childhood bullous pemphigoid following hepatitis B immunization. J Dermatol 2002: 29: 781-785.
41. Baykal C, Okan G, Sarica R. Childhood bullous pemphigoid developed after the first vaccination. J Am Acad Dermatol 2001: 44: 348-350.
42. Hertl M, Eming R, Veldman C. T cell control in autoimmune bullous skin disorders. J Clin Invest 2006: 116: 1156-1159.
43. Rensing-Ehl A et al. Frequency, function and CLA expression of CD4 ± CD25 ± FOXP3 ± regulatory T cells in bullous pemphigoid. Exp Dermatol 2007: 16: 13-21.